The objectives of this study were to (i) determine which of three simulated dosing regimens (gentamicin alone, simultaneous infusions of gentamicin and piperacillin, or staggered infusions of gentamicin and piperacillin) produced the fastest killing rate of Pseudomonas aeruginosa in serum, using the serum bactericidal rate (SBR) assay; and (ii) describe an alternative method of analysis of killing curves, the area under the killing curve (AUKC). Gentamicin alone or combined with piperacillin was added to heat-inactivated human serum to approximate drug concentrations achieved after the above-mentioned types of infusion. By a microdilution technique, seven strains of P. aeruginosa were exposed to no drug (control) Recently, the rate of serum bacterial killing, or serum bactericidal rate (SBR), has been investigated as a measure of the antimicrobial activity of antibiotics alone and in combination (5,7,26,29,(33)(34)(35). The SBR assay, first described by Drake et al. (7), is an abbreviated timed killing curve performed in serum, rather than broth. Unlike the timed killing curve method (18) (piperacillin). The antibiotic concentrations selected for testing were chosen such that they approximated those achieved in serum after the intravenous administration of gentamicin (2 mg/kg) alone, gentamicin (2 mg/kg) and piperacillin (4 g) simultaneously, or gentamicin (2 mg/kg) followed 3.5 h later 1500 Vol. 33,No. 9 on May 11, 2018 by guest http://aac.asm.org/ Downloaded from